Zhengye Biotechnology insider files Form 3

Zhengye Biotechnology Holding Ltd filed an initial insider ownership report for Vice General Manager Cheng Yuhong on Form 3.

Rhea-AI Filing Summary

Zhengye Biotechnology Holding Ltd filed an initial insider ownership report for Vice General Manager Cheng Yuhong on Form 3. This filing identifies Cheng as an officer of the company but shows no reported transactions, no derivative positions, and no current holdings entries at the time of this statement.

Key Figures

Buy transactions: 0 shares Sell transactions: 0 shares Derivative exercises: 0 shares +2 more

5 metrics

Buy transactions 0 shares buyShares in transactionSummary

Sell transactions 0 shares sellShares in transactionSummary

Derivative exercises 0 shares exerciseShares in transactionSummary

Holdings entries 0 holdingEntries in transactionSummary

Net buy/sell direction neutral netBuySellDirection in transactionSummary

Key Terms

Form 3, reporting person, derivative securities

3 terms

Form 3 regulatory

"Initial statement of beneficial ownership reported on Form 3."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"The reporting person is listed as Vice General Manager."

derivative securities financial

"No derivative securities appear in the derivativeSummary section."

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Zhengye Biotechnology (ZYBT) disclose in this Form 3 filing?

Zhengye Biotechnology reports an initial insider ownership statement for Vice General Manager Cheng Yuhong. The filing lists Cheng as an officer but shows no reported holdings, transactions, or derivative positions in the summarized data at the time of the report.

Who is the reporting person in Zhengye Biotechnology’s ZYBT Form 3?

The reporting person is Cheng Yuhong, identified as Vice General Manager of Zhengye Biotechnology Holding Ltd. Cheng is treated as an officer for insider reporting purposes, triggering the requirement to file this initial statement of beneficial ownership on Form 3.

Does the ZYBT Form 3 show any insider buying or selling activity?

No insider buying or selling is shown in the summarized Form 3 data. BuyCount, SellCount, and NetBuySellShares are all zero, indicating no reported open-market purchases, sales, or net share changes in this initial ownership statement.

Are there any derivative securities reported for Cheng Yuhong in ZYBT’s Form 3?

No derivative securities are reported for Cheng Yuhong in this Form 3. The derivativeSummary is empty and derivativeTransactionCount is zero, indicating no listed options, warrants, or other derivative positions in this initial insider ownership disclosure.

What does a holdingEntries value of zero mean in the ZYBT Form 3?

A holdingEntries value of zero means no specific security holdings are itemized in this Form 3 summary. The filing establishes Cheng Yuhong as a reportable officer but does not list individual equity positions or share counts in the provided structured data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 11:41 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cheng Yuhong (nmn)

(Last) (First) (Middle)

NO.1 LIANMENG ROAD

(Street)

JILIN CITY JILIN PROVINCE 132101

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/25/2026

3. Issuer Name and Ticker or Trading Symbol
Zhengye Biotechnology Holding Ltd [ ZYBT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice General Manager

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Yuhong Cheng	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)